Speaker illustration

Doctor Peter Perge

Semmelweis University, Budapest (Hungary)

Member of:

European Heart Rythm Association

Early rapid local impedance drop is associated with acute lesion efficacy during pulmonary vein isolation using a novel contact force sensing catheter

Event: ESC Congress 2022

Topic: Catheter Ablation of Arrhythmias

Session: Catheter ablation of atrial fibrillation – Insights in technical issues

Thumbnail

Early local impedance drop during pulmonary vein isolation using a novel contact force sensing catheter is associated with acute lesion efficacy

Event: EHRA 2022

Topic: Catheter Ablation of Arrhythmias

Session: Moderated ePosters - Variety on how to improve treatment of arrhythmias

Thumbnail

Accessory pathway mediated malignant ventricular arrhythmia importance of previously not diagnosed pre-excitation in the case of a young male after aborted sudden cardiac death.

Event: ESC Congress 2020

Topic: Clinical

Session: Tales of the Brave and Skillful from the EP and the Device Lab

Thumbnail

The predictive role of mitral regurgitation in heart failure patients of different etiology, undergoing cardiac resynchronization therapy

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Thumbnail

Novel biomarkers in cardiac resynchronization therapy: Hepatocyte growth factor is an independent predictor of clinical outcome

Event: EHRA 2018

Topic: Resynchronization Therapy

Session: CRT

Thumbnail

Hyperuricemia predicts mortality and the lack of reverse remodeling in CRT patients

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Results (Resynchronization therapy)

Session: Cardiac resynchronisation therapy

Thumbnail

Prognostic value of novel heart failure biomarkers in patients undergoing cardiac resynchronization therapy

Event: ESC Congress 2016

Topic: Resynchronisation therapy

Session: Tools to reduce ventricular arrhythmic in cardiac resynchronisation therapy patients and miscellaneous

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb